BACKGROUND: In aortic surgery bleeding complications can be fatal. Therefore, rotational thromboelastometry(ROTEM™)-based coagulation management was introduced. METHODS: After 5 cases of acute type A aortic dissection and aortic arch replacement had been treated based on ROTEM findings (ROTEM group; RG), 5 cases without ROTEM were matched as control group (CG). CG treatment was based on conventional tests and clinical findings. Blood component and coagulation factor requirements, ventilation time, duration of stay at intensive care unit (ICU), hospitalization, and thrombotic or bleeding incidents as well as transfusion-associated costs were compared. RESULTS: Administration of blood products and coagulation factor concentrates, ventilation time, ICU length of stay, and hospitalization tended to be lower in RG. Postoperative plasma transfusion (p = 0.038), recognized incidents (p = 0.048), and resulting costs on coagulation treatment (p = 0.049) were significantly reduced. CONCLUSION: Our data suggest that ROTEM-based coagulation management can reduce transfusion requirements and corresponding costs in patients with aortic arch replacement. These data has to be confirmed by prospective randomized trials.
BACKGROUND: In aortic surgery bleeding complications can be fatal. Therefore, rotational thromboelastometry(ROTEM™)-based coagulation management was introduced. METHODS: After 5 cases of acute type A aortic dissection and aortic arch replacement had been treated based on ROTEM findings (ROTEM group; RG), 5 cases without ROTEM were matched as control group (CG). CG treatment was based on conventional tests and clinical findings. Blood component and coagulation factor requirements, ventilation time, duration of stay at intensive care unit (ICU), hospitalization, and thrombotic or bleeding incidents as well as transfusion-associated costs were compared. RESULTS: Administration of blood products and coagulation factor concentrates, ventilation time, ICU length of stay, and hospitalization tended to be lower in RG. Postoperative plasma transfusion (p = 0.038), recognized incidents (p = 0.048), and resulting costs on coagulation treatment (p = 0.049) were significantly reduced. CONCLUSION: Our data suggest that ROTEM-based coagulation management can reduce transfusion requirements and corresponding costs in patients with aortic arch replacement. These data has to be confirmed by prospective randomized trials.
Authors: Michael K Banbury; Mariano E Brizzio; Jeevanantham Rajeswaran; Bruce W Lytle; Eugene H Blackstone Journal: J Am Coll Surg Date: 2005-11-10 Impact factor: 6.113
Authors: C Solomon; U Pichlmaier; H Schoechl; C Hagl; K Raymondos; D Scheinichen; W Koppert; N Rahe-Meyer Journal: Br J Anaesth Date: 2010-03-26 Impact factor: 9.166
Authors: Klaus Görlinger; Daniel Dirkmann; Alexander A Hanke; Markus Kamler; Eva Kottenberg; Matthias Thielmann; Heinz Jakob; Jürgen Peters Journal: Anesthesiology Date: 2011-12 Impact factor: 7.892
Authors: Jeffry L Kashuk; Ernest E Moore; Allison Sabel; Carlton Barnett; James Haenel; Tuan Le; Michael Pezold; Jerry Lawrence; Walter L Biffl; C Clay Cothren; Jeffrey L Johnson Journal: Surgery Date: 2009-10 Impact factor: 3.982
Authors: Babak Sarani; W Jonathan Dunkman; Laura Dean; Seema Sonnad; Jeffrey I Rohrbach; Vicente H Gracias Journal: Crit Care Med Date: 2008-04 Impact factor: 7.598
Authors: Stefan R B Schneider; Angelo M Dell'Aquila; Ali Akil; Dominik Schlarb; Guiseppe Panuccio; Sven Martens; Andreas Rukosujew Journal: Heart Vessels Date: 2014-12-10 Impact factor: 2.037
Authors: Raffael P C Zamper; Thiago C Amorim; Veronica N F Queiroz; Jordana D O Lira; Luiz Guilherme V Costa; Flavio Takaoka; Nicole P Juffermans; Ary S Neto Journal: BMC Anesthesiol Date: 2018-12-22 Impact factor: 2.217